BEQALZI™ (sonrotoclax), FDA‑Approved Treatment for Adults with R/R Mantle Cell Lymphoma, Available at Biologics by McKesson
Biologics by McKesson, an independent specialty pharmacy specializing in oncology, cell and gene, and rare disease therapies, has been selected by BeOne Medicines, a global oncology company, as a limited distribution specialty pharmacy provider for BEQALZI (sonrotoclax).
Biologics by McKesson Selected as Limited Distribution Specialty Pharmacy Provider for RASONQUE™(daraxonrasib)
Biologics by McKesson, an independent specialty pharmacy specializing in oncology, cell and gene, and rare disease therapies, has been selected by Revolution Medicines as a specialty pharmacy provider for RASONQUE™ (daraxonrasib) within its distribution network.
PALSONIFY™ (paltusotine), FDA-Approved for Treatment of Adults with Acromegaly Who Had an Inadequate Response to Surgery and/or for Whom Surgery Is Not an Option, Available at Biologics by McKesson
Biologics by McKesson was selected as a limited specialty pharmacy provider for PALSONIFY, the first once-daily oral therapy for adults with acromegaly who need an alternative to surgery.